4Tech said that it launched an FDA-approved U.S.-based early feasibility study of its TriCinch coil system intended to reduce tricuspid regurgitation, The first two successful implantations of the device were performed at Atlanta’s Piedmont Heart Hospital by Dr. Christopher Meduri, Dr. Vivek Rajagopal and Dr. Mani Vannan, the Ireland-based company said. “We are pleased to be the first center […]
4Tech
Tricuspid repair firm 4Tech taps ex-Boston Scientific execs for CEO, CMO | Personnel Moves for Feb. 27, 2018
4Tech said last week that it named a pair of Boston Scientific (NYSE:BSX) veterans as its new CEO and CMO, with onetime chief Mike Ennen stepping away for “family reasons.” Galway, Ireland-based 4Tech said former Boston transcatheter aortic valve GM Tom Fleming is slated to take the reins from Thoratec vet Ennen as president & CEO in […]
4tech launches transcatheter tricuspid valve repair feasibility trial
Transcatheter tricuspid heart valve repair device developer 4Tech said today it launched a feasibility trial of its TriCinch device designed to treat patients suffering from tricuspid regurgitation. The TriCinch system is the 1st transcatheter device designed to repair diseased tricuspid heart valves through in interventional procedure, the Galway, Ireland-based company said. “Today’s standard for treating […]
